Belantamab mafodotin does not induce B-cell maturation antigen loss or systemic immune dysfunction in multiple myeloma
Belantamab mafodotin 不会引起多发性骨髓瘤患者的 B 细胞成熟抗原丢失或全身免疫功能障碍。
期刊:Haematologica
影响因子:7.9
doi:10.3324/haematol.2025.288203
Musa, Hanny; Mielnik, Michał; Trudel, Suzanne; Weisel, Katja; Mockus-Daehn, Taryn; Ferron-Brady, Geraldine; Hong, Qingqing; Ma, Yinjiao; Patel, Sagar; Suchindran, Sunil; Zhou, Xiangdong; Richardson, Paul G; Cohen, Adam D; Lowther, Daniel E